Highland Capital Management (Texas)’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | $373K | Hold |
2,632
| – | – | 0.02% | 236 |
|
|
2019
Q1 | $382K | Sell |
2,632
-5,000
| -66% | -$726K | 0.02% | 229 |
|
|
2018
Q4 | $864K | Buy |
7,632
+5,000
| +190% | +$566K | 0.07% | 164 |
|
|
2018
Q3 | $354K | Sell |
2,632
-1,700
| -39% | -$229K | 0.02% | 254 |
|
|
2018
Q2 | $486K | Buy |
4,332
+1,750
| +68% | +$196K | 0.03% | 199 |
|
|
2018
Q1 | $276K | Hold |
2,582
| – | – | 0.01% | 282 |
|
|
2017
Q4 | $283K | Hold |
2,582
| – | – | 0.01% | 250 |
|
|
2017
Q3 | $279K | Hold |
2,582
| – | – | 0.01% | 248 |
|
|
2017
Q2 | $261K | Hold |
2,582
| – | – | 0.01% | 263 |
|
|
2017
Q1 | $232K | Sell |
2,582
-1,250
| -33% | -$112K | 0.01% | 250 |
|
|
2016
Q4 | $292K | Hold |
3,832
| – | – | 0.01% | 254 |
|
|
2016
Q3 | $319K | Sell |
3,832
-79,408
| -95% | -$6.61M | 0.01% | 243 |
|
|
2016
Q2 | $6.86M | Buy |
+83,240
| New | +$6.86M | 0.28% | 80 |
|